These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34692493)
1. HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression. Chang YF; Yan GJ; Liu GC; Hong Y; Chen HL; Jiang S; Zhong Y; Xiyang YB; Hu T Front Oncol; 2021; 11():718781. PubMed ID: 34692493 [TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation. Meng Q; Zhang Y; Sun H; Yang X; Hao S; Liu B; Zhou H; Wang Y; Xu ZX Redox Biol; 2024 May; 71():103108. PubMed ID: 38457903 [TBL] [Abstract][Full Text] [Related]
3. Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses. Hu T; Li YS; Chen B; Chang YF; Liu GC; Hong Y; Chen HL; Xiyang YB Exp Biol Med (Maywood); 2015 Oct; 240(10):1287-97. PubMed ID: 25616277 [TBL] [Abstract][Full Text] [Related]
4. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1. Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542 [TBL] [Abstract][Full Text] [Related]
5. HPV16 E6 regulates the proliferation, invasion, and apoptosis of cervical cancer cells by downregulating miR-504. Zhang L; Lai Y; Sun Y; Xu B; Qiang X; Zhou X; Wang T Transl Cancer Res; 2020 Dec; 9(12):7588-7595. PubMed ID: 35117358 [TBL] [Abstract][Full Text] [Related]
6. HPV16 E6 promotes cell proliferation, migration, and invasion of human cervical cancer cells by elevating both EMT and stemness characteristics. Lu Y; Chen Y; Zhang Z; Li M; Chen X; Tu K; Li L Cell Biol Int; 2022 Apr; 46(4):599-610. PubMed ID: 34957655 [TBL] [Abstract][Full Text] [Related]
7. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter. Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279 [TBL] [Abstract][Full Text] [Related]
8. HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression Shu S; Li Z; Liu L; Ying X; Zhang Y; Wang T; Zhou X; Jiang P; Lv W Front Oncol; 2022; 12():900856. PubMed ID: 35875100 [TBL] [Abstract][Full Text] [Related]
10. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer. Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK Virol J; 2016 Apr; 13():60. PubMed ID: 27044426 [TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells. He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257 [TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women. Gallagher KME; Man S J Gen Virol; 2007 May; 88(Pt 5):1470-1478. PubMed ID: 17412975 [TBL] [Abstract][Full Text] [Related]
13. IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer. Rho SB; Lee SH; Byun HJ; Kim BR; Lee CH Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076322 [TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia. Omran OM; AlSheeha M Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218 [TBL] [Abstract][Full Text] [Related]
15. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78. Ajiro M; Zheng ZM mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589 [TBL] [Abstract][Full Text] [Related]
16. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
17. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo. Hu D; Zhou J; Wang F; Shi H; Li Y; Li B Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522 [TBL] [Abstract][Full Text] [Related]
18. [The role of human papillomavirus 16 early genes E2 and E6 and heterogeneous nuclear ribonucleoprotein E2 in cervical carcinogenesis and their interaction effect]. Gao W; Ding L; Song ZC; Feng MJ; Liu CL; Li XX; Song L; Lyu YJ; Wang JT Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jan; 54(1):92-98. PubMed ID: 31914575 [No Abstract] [Full Text] [Related]
19. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo. Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977 [TBL] [Abstract][Full Text] [Related]
20. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells. Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]